NCT04202549View on ClinicalTrials.gov

Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Intra-arterial Cocktail Therapy (INSIST-CT)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 15, 2019

Primary Completion Date

September 20, 2022

Study Completion Date

September 20, 2022

Conditions
Ischemic Stroke
Interventions
DRUG

intra-arterial cocktail therapy

Intra-arterial administration of argatroban (0.2-0.3 mg/min), dexamethasone (0.1 mg/min) and edaravone (0.3 mg/min) for 30 to 60 minutes after thrombectomy.

Trial Locations (1)

110840

General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

Hui-Sheng Chen

OTHER

NCT04202549 - Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Intra-arterial Cocktail Therapy (INSIST-CT) | Biotech Hunter | Biotech Hunter